Package 60687-481-21

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 60687-481-21
Digits Only 6068748121
Product NDC 60687-481
Product ID 60687-481_2a815afd-4f27-120b-e063-6394a90a82a0
Description

30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-481-21) / 1 TABLET in 1 BLISTER PACK (60687-481-11)

Marketing

Marketing Status
Marketed Since 2020-02-06
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

Buprenorphine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "2a815afd-4f27-120b-e063-6394a90a82a0", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["8d38f7aa-da0b-40ad-b0d1-4284c71042ed"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-481-21)  / 1 TABLET in 1 BLISTER PACK (60687-481-11)", "package_ndc": "60687-481-21", "marketing_start_date": "20200206"}], "brand_name": "Buprenorphine", "product_id": "60687-481_2a815afd-4f27-120b-e063-6394a90a82a0", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "60687-481", "dea_schedule": "CIII", "generic_name": "Buprenorphine", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA207276", "marketing_category": "ANDA", "marketing_start_date": "20200206", "listing_expiration_date": "20261231"}